There are several factors that make this technology desirable for physicians. First, it removes the subjective nature of diagnosing nevi for their cancerous properties or potential. As a result, the results are more consistent and much more accurate.
It will also enable physicians to diagnose cancer at an early, more curable stage in its development which will enable both a greater cure rate and significantly lower treatment costs.
Next, it will reduce the potential for misdiagnosis, false positives, and residual damage from biopsies such as scarring.
Finally, this diagnostic tool will have less impact on the healthcare system. Physicians can complete the diagnostic tests in their offices. And because of its greater accuracy, the need for many biopsies will be eliminated. Biopsy samples must be stored and transported to laboratories for expert analysis. This adds extra costs and increases the possibility that samples might be mishandled, destroyed or lost.